- Global Pharma News & Resources

Cushings Syndrome Market 2019 Global Industry Size, Share, Trends, Growth Factors, Key Countries Analysis By Leading Players With Forecast to 2026

Global Cushing’s Syndrome Market

Cushing’s syndrome is a disorder that occurs when the body makes too much of the hormone cortisol over a long period of time. The most common symptoms of the disorder include high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders, and fragile skin that takes long to heal. It is found that the condition occurs due to prolonged exposure to high cortisol levels. Cortisol is sometimes called the ‘stress hormone’, as it makes the body respond to stress. Cortisol also helps maintain blood pressure and regulates blood glucose. However, excessive use of cortisol-like medications, such as prednisone, or tumor growth resulting from excessive cortisol secretion by the adrenal glands, are the two basic factors that cause the Cushing’s syndrome. Other tumors, associated with certain inherited disorders, such as multiple endocrine neoplasia type 1 and Carney complex, may also lead to this disease. In most cases, the disease can be treated and cured by surgery, radiation, or use of steroids.

Request Sample Copy of the Business Report:

According to experts, the most significant cause of Cushing’s syndrome is the excessive intake of glucocorticoids prescribed by a healthcare professional to cure other diseases, such as asthma, rheumatoid arthritis, or immunosuppression post an organ transplant. Moreover, the administration of synthetic ACTH can also lead to the condition. It may also occur in animals like cats, dogs, and horses. Apparently, all of the abovementioned factors are expected to favor the growth of the global Cushing’s syndrome market.

Global Cushing’s Syndrome Market Taxonomy

By Drug Type:

  • Etomidate
  • Ketoconazole
  • Pasireotide
  • Aminoglutethimide
  • Mitotane
  • Metyrapone
  • Mifepristone

By End User:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Clinics
  • Drug Stores
  • E-Commerce/Online Pharmacies

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Rise in production of the cortisol hormone in the body fuels the of Cushing’s syndrome market growth

Cushing’s syndrome is also known as hypercortisolism, as it is basically a hormonal disorder caused due to a prolonged exposure of the body’s tissues to high levels of cortisol. Adults aged between 20 to 50 years are mostly known to suffer from Cushing’s syndrome. The global Cushing’s syndrome market is projected to witness growth due to rising awareness about the disorder and increasing healthcare expenditures. With increased research and development, various new drugs, such as ketoconazole, metyrapone, and mitotane, have been made available globally to minimize the surgical risks for patients. According to the Orphanet Journal of Rare Disease, the incidence of Cushing’s syndrome is estimated to be equivalent to 1-3 cases per million inhabitants every year.

Regional growth engines support the global Cushing’s syndrome market

The global Cushing’s syndrome is geographically segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America stands out as the leading market for Cushing’s syndrome, owing to the presence of a high income standard and rising health awareness among the populace. The Centers for Disease Control and Prevention (CDC) reported that more than one-third of the adult population in the U.S. suffers from obesity, which is one of the primary causes of the disease.

To understand Research Methodology, please click

Global Cushing’s Syndrome Market – Competitive Background

The key players operating in the global Cushing’s syndrome market include Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma Plc, and Novartis AG.

Strongbrigde Biopharma Plc observed a major surge in its research and development activities in 2016, which included development of clinical trials for RECORLEV for the treatment of endogenous Cushing’s syndrome. With such progress, the company is expected to create high competition among its peers, and also strengthen its global market presence.

Table of Content

Global Cushings Syndrome Market Research Report
Section 1: Global Cushings Syndrome Industry Overview
Section 2: Global Economic Impact on Cushings Syndrome Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cushings Syndrome Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Cushings Syndrome Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 03-Mar-2021